Early oligoarthritis

Rheumatic Disease Clinics of North America

Volumn 31, Issue 4, 2005, Pages 627-639

  Marzo Ortega, Helena ^a   Cawkwell, Lorna ^a   Green, Michael J ^a,b,c  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZITHROMYCIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALAZOSULFAPYRIDINE;

ANTIBIOTIC THERAPY; ARTHRITIS; ARTHROSCOPY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMAGING; LABORATORY TEST; MEDICAL ASSESSMENT; MICROBIOLOGICAL EXAMINATION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RADIOGRAPHY; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; TREATMENT OUTCOME; ULTRASOUND;

ARTHRITIS; EARLY DIAGNOSIS; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 27744543458     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.07.010     Document Type: Review

References (54)

1. Hübscher O. Pattern recognition in arthritis. In: Klippel J.H., Dieppe P.A., editors. Rheumatology. 2nd edition, vol. 1. St. Louis (MO): Mosby; 1998. p. 2;3.1-3.6
2. C. Egmose, T.M. Hansen, and L.S. Andersen Limited effect of sulphasalazine treatment in reactive arthritis: a randomized double blind placebo controlled trial Ann Rheum Dis 56 1997 32 36
3. J.D. Parker, and H.A. Capell An acute arthritis clinic-one years experience Br J Rheumatol 25 1986 293 295
4. A. Glennas, T.K. Kvein, and K. Melby Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome Br J Rheumatol 34 1 1995 45 50
5. A. Toivanen, and P. Toivanen Reactive arthritis Curr Opin Rheumatol 12 4 2000 300 305
6. Fan P.T., Yu D.T.Y. Spondyloarthropathies. In: Kelley W.N., Harris Jr ED, Ruddy S., Sledge C.B., editors. Textbook of rheumatology. 4th edition, vol. 1. Philadelphia: WB Saunders; 1993. p. 59-69
7. S. Schnarr, N. Putschky, and M.C. Jendro Chlamydia and Borrellia DNA in synovial fluid of patients with early undifferentiated oligoarthritis Arthritis Rheum 4 2001 2679 2685
8. C. Fendler, S. Laitko, and H. Sorensen Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis Ann Rheum Dis 60 2001 337 343
9. M. Leirisalo-Repo Enteric infections and arthritis: clinical aspects A. Calin J.D. Taurog The spondyloarthropathies 1998 Oxford University Press Oxford
10. A. Keat Reiter's syndrome and reactive arthritis in perspective N Engl J Med 309 1983 1606 1615
11. K. Aho, M. Leirisalo-Repo, and H. Repo Reactive arthritis Clin Rheum Dis 11 1985 25 40
12. J.G. Kuipers, K. Scharmann, and J. Wollenphaut Sensitivities of PCR, Microtrak, Chlamydia EIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid J Clin Microbiol 33 1995 3186 3190
13. F.C. Arnett, J.D. Reveille, and M. Duvic Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection Rheum Dis Clin North Am 17 1991 59 78
14. M.L. Cuellar, and L.R. Espinoza Human immunodeficiency virus associated spondyloarthropathy: lessons from the third world J Rheumatol 26 1999 2071 2073
15. D. McGonagle, S. Reade, and H. Marzo-Ortega Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment Ann Rheum Dis 60 2001 696 698
16. L.R. Espinoza, and M.L. Cuellar Psoriatic arthritis and spondylitis: a clinical approach A. Calin J.D. Taurog The spondyloarthropathies 1998 Oxford University Press Oxford 97 111
17. M. Scatterkirchner, and K. Kruger Natural course and prognosis of HLA-B27 positive oligoarthritis Clin Rheumatol 6 Suppl 2 1987 83 86
18. J.K. Jantti, K. Kaarela, and K.E.S. Lehtinen Seronegative oligoarthritis: a 23 year follow-up study Clin Rheumatol 21 2002 353 356
19. M.A. Quinn, P.G. Conaghan, and P. Emery The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatol 40 2001 1211 1220
20. M.J. Green, H. Marzo-Ortega, and R.J. Wakefield Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints Arthritis Rheum 44 2001 1177 1183
21. H. Marzo-Ortega, M.J. Green, and A.M. Keenan A randomized trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months Arthritis Rheum 50 2004 S198
22. M. Dougados, S. van der Linden, and R. Juhlin The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy Arthritis Rheum 34 1991 1218 1227
23. B. Amor, M. Dougados, and M. Mijiyawa Critères de classification des spondylarthropathies Rev Rhum 57 1990 85 89
24. P.G. Conaghan, P. O'Connor, and D. Mc Gonagle Elucidation of the relationship between synovitis and bone damage: a randomised magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis Arthritis Rheum 48 2003 64 71
25. F.M. McQueen, N. Benton, and D. Perry Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis Arthritis Rheum 48 2003 1814 1827
26. D. McGonagle, P.G. Conaghan, and P. O'Connor The relationship of synovitis and bone oedema changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study Arthritis Rheum 42 1999 1706 1711
27. D. McGonagle, W. Gibbon, and P. O'Connor Characteristic magnetic resonance imaging entheseal changes in knee synovitis in spondyloarthropathy Arthritis Rheum 41 1998 694 700
28. V. Jevtic, I. Watt, and B. Razman Distinctive radiological features of small hand joint arthritis in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging Skel Radiol 24 1995 351 355
29. H. Marzo-Ortega, D. McGonagle, and P. O'Connor Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondyloarthropathy. A clinical and magnetic resonance imaging Arthritis Rheum 44 2001 2112 2117
30. J. Braun, X. Baralakios, and W. Golder Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system Arthritis Rheum 48 2003 1126 1136
31. X. Baralakios, R. Landewe, and K.-G. Hermann Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging Ann Rheum Dis 64 2005 730 734
32. R.J. Wakefield, W.W. Gibbon, and P.G. Conaghan The value of ultrasonography in the detection of bone erosion in patients with rheumatoid arthritis: a comaparative study with conventional radiography Arthritis Rheum 43 2000 2762 2770
33. M. Backhaus, T. Kamradt, and D. Sandrock Arthritis of the finger joints-a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging Arthritis Rheum 42 1999 232 245
34. R.J. Wakefield, M.J. Green, and H. Marzo-Ortega Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease Ann Rheum Dis 63 2004 382 385
35. M.C. Kraan, H. Versendaal, and M. Jonker Asymptomatic synovitis precedes clinically manifest arthritis Arthritis Rheum 41 1998 1481 1488
36. J.R. Kirwan The relationship between synovitis and erosions in rheumatoid arthritis Br J Rheumatol 36 2 1997 225 228
37. H. Marzo-Ortega, H. Green, and Z. Karim Non-steroidal anti-inflammatory drugs alter the presentation of early inflammatory arthritis Rheumatol 39 Suppl 1 2000 42
38. J. Devlin, A. Gough, and A. Huisson Knee disease in 766 early arthritis patients, relevance to outcome and pathogenesis Clin Rheumatol 19 2000 82 85
39. M.A. Quinn, M.J. Green, and H. Marzo-Ortega Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol Arthritis Rheum 48 11 2003 3039 3045
40. D.O. Clegg, D.J. Reda, and E. Mejias Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Depatment of Veterans Affairs Cooperative study Arthritis Rheum 39 12 1996 2013 2020
41. M. Dougados, S. van der Linden, and M. Leirisalo-Repo Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study Arthritis Rheum 38 5 1995 618 627
42. D. Lacaille, H.B. Stein, J. Raboud, and A.V. Klinkhoff Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate? J Rheumatol 27 8 2000 1922 1927
43. E. Kruithof, F. Van den Bosch, and D. Baeten Repeated infusions of infliximab, a chimeric anti-TNF alpha monoclonal antibody in patients with active spondyloarthropathy: one year follow up Ann Rheum Dis 61 2002 207 212
44. J.D. Gorman, K.E. Sack, and J.C. Davis Jr Treatment of ankylosing spondylitis by inhibition of tumour necrosis factor alpha N Engl J Med 346 2002 1349 1356
45. P.J. Mease, B.S. Gaffe, and J. Metz Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized controlled trial Lancet 356 2000 385 390
46. H. Marzo-Ortega, D. McGonagle, and A.L. Tan A clinical and magnetic resonance imaging assessment of the efficacy of infliximab at a dose of 3 mg/kg in combination with methotrexate in the treatment of psoriatic arthritis Rheumatol 43 Suppl 2 2004 29
47. C. Antoni, A. Kavanaugh, and D. Gladman The infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analysis after one year Arthritis Rheum 50 2004 S450
48. M.A. Quinn, P.G. Conaghan, and P.J. O'Connor Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage with sustained benefit after infliximab withdrawal Arthritis Rheum 52 2005 27 35
49. T.K. Kvien, A. Glennas, and K. Melby Reactive arthritis: incidence, triggering agents and clinical presentation J Rheumatol 21 1994 115 122
50. T. Yli-Kerttula, R. Luukkainen, and U. Yli-Kerttula Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis Ann Rheum Dis 62 9 2003 880 884
51. J. Sieper, C. Fendler, and S. Laitko No benefit of long term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. A three month, multicenter, double blind, randomized, placebo controlled study Arthritis Rheum 7 1999 1386 1396
52. K. Laasila, L. Laasonen, and M. Leirisalo-Repo Antibiotic treatment and long-term prognosis of rective arthritis Ann Rheum Dis 62 7 2003 655 658
53. J. Sieper, J. Braun, and G.H. Kingsley Report on the fourth international workshop on reactive arthritis Arthritis Rheum 4 2000 720 734
54. E.M. Ayoub, and H.A. Majeed Poststreptococcal reactive arthritis Curr Opin Rheumatol 12 2000 306 310